Beta Adrenoceptor Antagonists After Myocardial Infarction--where Are We Now?

Overview

Journal Br Heart J

Specialty Cardiology & Vascular Diseases

Date 1983 Feb 1

PMID 6130777

Citations 10

Authors

D A Chamberlain

Affiliations

Soon will be listed here.

Citing Articles

Exercise testing early after myocardial infarction: discussion paper.

Handler C J R Soc Med. 1983; 76(7):569-73.

PMID: 6876048 PMC: 1439099. DOI: 10.1177/014107688307600709.

Anti-arrhythmic effects of prazosin and propranolol during coronary artery occlusion and re-perfusion in dogs and pigs.

Benfey B, Elfellah M, OGILVIE R, Varma D Br J Pharmacol. 1984; 82(3):717-25.

PMID: 6743921 PMC: 1987014. DOI: 10.1111/j.1476-5381.1984.tb10811.x.

Exercise testing to identify high risk patients after myocardial infarction.

Handler C J R Coll Physicians Lond. 1984; 18(2):124-7.

PMID: 6726665 PMC: 5370918.

Prediction of mortality in hospital survivors of myocardial infarction. Comparison of predischarge exercise testing and radionuclide ventriculography at rest.

Fioretti P, Brower R, Simoons M, Das S, Bos R, Wijns W Br Heart J. 1984; 52(3):292-8.

PMID: 6466515 PMC: 481627. DOI: 10.1136/hrt.52.3.292.

Hypoxia-induced cardiac hypertrophy in rabbits treated with verapamil and nifedipine.

Dukes I, VAUGHAN WILLIAMS E Br J Pharmacol. 1983; 80(2):241-7.

PMID: 6228279 PMC: 2045028. DOI: 10.1111/j.1476-5381.1983.tb10026.x.

References

Hansteen V, MOINICHEN E, Lorentsen E, Andersen A, Strom O, Soiland K . One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. Br Med J (Clin Res Ed). 1982; 284(6310):155-60. PMC: 1495539. DOI: 10.1136/bmj.284.6310.155. View

Alvan G, von Bahr C, Seidemann P, Sjoqvist F . High plasma concentrations of beta-receptor blocking drugs and deficient debrisoquine hydroxylation. Lancet. 1982; 1(8267):333. DOI: 10.1016/s0140-6736(82)91583-5. View

Ramsdale D, Faragher E, Bennett D, Bray C, Ward C, Cruickshank J . Ischemic pain relief in patients with acute myocardial infarction by intravenous atenolol. Am Heart J. 1982; 103(4 Pt 1):459-67. DOI: 10.1016/0002-8703(82)90330-1. View

Sanz G, Castaner A, Betriu A, Magrina J, Roig E, Coll S . Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study. N Engl J Med. 1982; 306(18):1065-70. DOI: 10.1056/NEJM198205063061801. View

Julian D, Prescott R, Jackson F, SZEKELY P . Controlled trial of sotalol for one year after myocardial infarction. Lancet. 1982; 1(8282):1142-7. DOI: 10.1016/s0140-6736(82)92225-5. View

Sainte-Rose C, Roux F, Renier D, Pierre-Kahn A, Hirsch J . [Intra-cranial abscesses and congenital heart disease in children (author's transl)]. Neurochirurgie. 1982; 28(1):33-40. View

Lewis J . Beta-blockade after myocardial infarction--a statistical view. Br J Clin Pharmacol. 1982; 14 Suppl 1:15S-21S. PMC: 1427463. DOI: 10.1111/j.1365-2125.1982.tb02055.x. View

Han J, GARCIADEJALON P, MOE G . ADRENERGIC EFFECTS ON VENTRICULAR VULNERABILITY. Circ Res. 1964; 14:516-24. DOI: 10.1161/01.res.14.6.516. View

Grayson J, Irvine M, Parratt J, Cunningham J . Vasospastic elements in myocardial infarction following coronary occlusion in the dog. Cardiovasc Res. 1968; 2(1):54-62. DOI: 10.1093/cvr/2.1.54. View

10.

Norris R, Caughey D, Scott P . Trial of propranolol in acute myocardial infarction. Br Med J. 1968; 2(5602):398-400. PMC: 1985983. DOI: 10.1136/bmj.2.5602.398. View

11.

Wolfson S, Gorlin R . Cardiovascular pharmacology of propranolol in man. Circulation. 1969; 40(4):501-11. DOI: 10.1161/01.cir.40.4.501. View

12.

Lemberg L, CASTELLANOS Jr A, Arcebal A . The use of propranolol in arrhythmias complicating acute myocardial infarction. Am Heart J. 1970; 80(4):479-87. DOI: 10.1016/0002-8703(70)90195-x. View

13.

MICHELAKIS A, McALLISTER R . The effect of chronic adrenergic receptor blockade on plasma renin activity in man. J Clin Endocrinol Metab. 1972; 34(2):386-94. DOI: 10.1210/jcem-34-2-386. View

14.

SHAND D, Rangno R . The disposition of propranolol. I. Elimination during oral absorption in man. Pharmacology. 1972; 7(3):159-68. DOI: 10.1159/000136285. View

15.

Mueller H, Ayres S, Religa A, Evans R . Propranolol in the treatment of acute myocardial infarction. Effect on myocardial oxygenation and hemodynamics. Circulation. 1974; 49(6):1078-87. DOI: 10.1161/01.cir.49.6.1078. View

16.

Wilhelmsson C, Vedin J, Wilhelmsen L, Tibblin G, WERKO L . Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results. Lancet. 1974; 2(7890):1157-60. DOI: 10.1016/s0140-6736(74)90807-1. View

17.

Verrier R, Thompson P, LOWN B . Ventricular vulnerability during sympathetic stimulation: role of heart rate and blood pressure. Cardiovasc Res. 1974; 8(5):602-10. DOI: 10.1093/cvr/8.5.602. View

18.

Barber J, Boyle D, Chaturvedi N, Singh N, Walsh M . Practolol in acute myocardial infarction. Acta Med Scand Suppl. 1976; 587:213-9. DOI: 10.1111/j.0954-6820.1976.tb05884.x. View

19.

Weksler B, Gillick M, Pink J . Effect of propranolol on platelet function. Blood. 1977; 49(2):185-96. View

20.

Newman R . Comparison of the antilipolytic effect of metoprolol, acebutolol, and propranolol in man. Br Med J. 1977; 2(6087):601-3. PMC: 1631536. DOI: 10.1136/bmj.2.6087.601. View